Manufacturing of pharmaceutical formulations and related services in India.
Annual revenue $1.7M Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products 2 Services tracked
Competitors - Brand Intelligence

About M Sea Pharmaceuticals

M Sea Pharmaceuticals is a company. M Sea Pharmaceuticals offers products and services including Capsules and Dry Syrup.

  • Sectors
    Industrial Goods & Manufacturing
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Legal Name M Sea Pharmaceuticals Pvt. Ltd
  • Jurisdiction Himachal Pradesh, Himachal Pradesh, India
Operational Areas
Industrial Goods & Manufacturing → Contract & Custom Manufacturing Unlock Sub-Sector Unlock Segment
Healthcare → Pharmaceuticals & Therapeutics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $1.65 M (USD)
    27.02
    as on Mar 31, 2022
  • Net Profit
    $13.46 K (USD)
    14.66
    as on Mar 31, 2022
  • EBITDA
    $80 K (USD)
    15.5
    as on Mar 31, 2022
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of M Sea Pharmaceuticals

M Sea Pharmaceuticals offers a comprehensive portfolio of products and services, including Capsules and Dry Syrup.

Product name locked
Category locked
Primary

Capsules are produced for both Beta Lactum and non-Beta Lactum uses as part of the pharmaceutical formulations offered.

Product name locked
Category locked
Locked

Dry syrup formulations are manufactured for Beta Lactum products to ensure they meet required therapeutic standards.

Funding Insights of M Sea Pharmaceuticals

Premium access

Detailed funding history for M Sea Pharmaceuticals

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by M Sea Pharmaceuticals

Investments
Premium access

Investment portfolio details for M Sea Pharmaceuticals

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - M Sea Pharmaceuticals

Premium access

Detailed financials for M Sea Pharmaceuticals

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

M Sea Pharmaceuticals Comparisons

M Sea Pharmaceuticals Primary company
Description
Manufacturing of pharmaceutical formulations and related ser...
Location
-
Founded Year
-
Annual Revenue
$1.65 M (USD)
Net Profit
$13.46 K (USD)
EBITDA
$80 K (USD)
Employees
Not available
Premium access

Peer comparison for M Sea Pharmaceuticals

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of M Sea Pharmaceuticals

Premium access

Detailed competitors of M Sea Pharmaceuticals

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on M Sea Pharmaceuticals

Premium access

Complete news archive for M Sea Pharmaceuticals

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about M Sea Pharmaceuticals

Annual revenue of M Sea Pharmaceuticals is $1.65M as on Mar 31, 2022.

M Sea Pharmaceuticals Pvt. Ltd. is recognized as a pharmaceutical manufacturer based in India, certified with ISO 9001-2015, GLP, and WHO GMP standards. It is engaged in producing formulations such as tablets, capsules, dry syrups, and oral liquids, with facilities designed to comply with international manufacturing norms. A commitment to quality and safety is upheld, ensuring formulations meet regulatory guidelines. Services include contract and third-party manufacturing for Beta Lactum products, supporting business alliances in the sector. This approach is maintained to deliver reliable therapeutic options.

M Sea Pharmaceuticals offers Capsules and Dry Syrup.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available